Sort
17,288 grants matching “multiple sclerosis”
Core-002
$244,509Donna L Farber · Columbia University Health Sciences · U19 · FY2025 · AI
Cannabinoid Inhibition of Divalent Metal Transporter-1 Activity
$244,500Marianne Wessling-Resnick · Harvard School Of Public Health · R21 · FY2008 · DA
Identification of a protein that elicits immune-mediated neuronal dysfunction
$244,500Bonnie N Dittel · Versiti Wisconsin, Inc. · R21 · FY2009 · NS
Chemokines and Viral-Induced Neurologic Disease
$244,452University Of California Irvine · R01 · FY2003 · NS
MODULATION OF AUTOREACTIVE T CELLS
$244,424University Of Missouri-Columbia · R01 · FY2002 · NS
Novel Therapies for Epilepsy Using Biodegradable Immune-Modifying Nanoparticles
$244,405Stephen D Miller · Northwestern University At Chicago · R21 · FY2015 · NS
A role for endogenous retroelements in Aicardi-Goutieres Syndrome
$244,375John L Goodier · Johns Hopkins University · R21 · FY2016 · HD
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$244,258Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
A Targeted Preemptive Approach to Addressing Mitochondrial Toxicity of Nucleoside
$244,241John K. Buolamwini · Rosalind Franklin Univ Of Medicine & Sci · R01 · FY2015 · GM
Synergy between T cells and Complement in EAE
$244,220Feng Lin · Case Western Reserve University · R01 · FY2006 · NS
Quantitative myelin mapping in vivo for clinical and pre-clinical MRI
$244,055Vasily L. Yarnykh · University Of Washington · R24 · FY2021 · NS
Investigating whole-body innate immune activation in Alzheimer's disease using PET imaging and immune profiling
$244,019Aisling Chaney · Washington University · R00 · FY2025 · AG
Chemokines and Viral-Induced Neurologic Disease
$243,949University Of California Irvine · R01 · FY2004 · NS
Quantitative Modeling of Segmental Timing in Dysarthria
$243,916Jan P Van Santen · Oregon Health & Science University · R21 · FY2009 · DC
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
$243,881Iain Leslie Campbell · University Of Sydney · R01 · FY2006 · NS
Development of Peptide Targeting Technology for Demyelinating Lesions
$243,750Barbara Ranscht · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2017 · NS
Evaluation of a High-Affinity and BTLA-specific HVEM Protein Agonist in vivo
$243,750Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2021 · AI
Phage Display Detection of Alzheimer's Disease Markers
$243,750Erkki I Ruoslahti · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2019 · AG
Statistical methods in smoking cessation research
$243,721Daniel F. Heitjan · University Of Pennsylvania · R01 · FY2007 · CA
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells
$243,596Xitiz Chamling · Johns Hopkins University · R00 · FY2023 · EY
High Precision Biochips of Membrane Mimics for Blood Biomarker Assessment
$243,589Quan Jason Cheng · University Of California Riverside · R21 · FY2018 · AI
A Novel PET Ligand for PBR Imaging
$243,540Christopher J Endres · Johns Hopkins University · R21 · FY2011 · MH
NEURON-GLIA INTERACTIONS
$243,516University Of Puerto Rico Med Sciences · P01 · FY2001 · NS
Patient-adjustable MRI technology for high-resolution imaging of deep brain stimulation
$243,469Laleh Golestani Rad · Northwestern University At Chicago · R00 · FY2019 · EB
Patient-adjustable MRI technology for high-resolution imaging of deep brain stimulation
$243,469Laleh Golestani Rad · Northwestern University At Chicago · R00 · FY2020 · EB